OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 02, 2023
Decreasing vein to vein time saves lives.
March 01, 2023
There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.
November 17, 2022
A novel mathematical approach for fitting concentration-response curves is proposed that offers a more accurate estimation of potency data.
November 02, 2022
Increasing molecular diversity is creating a need for the reinvention of process development and control strategies.
October 01, 2022
A simplified downstream process can save time and costs but requires enabling technologies.
August 02, 2022
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
July 02, 2022
The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.
July 01, 2022
As we reach further afield in the molecular universe, we encounter new types of problems to resolve.
June 21, 2022
Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites.
May 03, 2022
An increasingly complex development pipeline and industry considerations, such as sustainability, are leading to a greater need for more efficient separation and purification in downstream processing.